A Study on the Role of Hypokalemia in Infections with Covid-19 Virus in Babylon province
Keywords:
COVID-19, ACE2, rennin-angiotensin system (RAS), potassium, ICTVAbstract
Droplets from a person who has COVID can spread to others mostly through their cough or sneeze. The management of the contagion and eventual control of it, therefore, appears to depend on its early and correct diagnosis. Additionally, the fact that COVID infections can manifest clinically in a variety of ways, from not appearing in any significant to severe states, emphasizes the need for quick, easy, accurate, and early detection techniques. This article discusses the effects of potassium ions on human organ function and potential contributions to the development of COVID-19 disease. The study included 50 samples, 30 people had Corona diseases with hypokalemia and 20 without hypokalemia persons, but didn't get any medical treatment. All of the cases were checked, and the results of the patients and the control group were statistically compared. All tests and samples were done at Marjan Teaching Hospital in Babil province from June 2021 to November 2021. People between the ages of 17 and 60 years took part in the study. Potassium estimation methods for all samples from blood Samples examine by using emission photometry (colorimetric) or by blood electrolytes (ST-200CC) blood analysis. Results: By June 15, 2021, 50 patients with COVID-19 (15 women and 35 men; age [17–60] years) were admitted to hospital in Marjan Teaching Hospital in Babil province from June 2021 to November 2021, consisting of 30 patients had severe hypokalemia with covid -19, 20 without hypokalemia-, the results were significantly associated with the severity of hypokalemia (P<0.001),60% of severe and critically ill patients had hypokalemia which was most common among patients covid -19. Hypokalemia was mostly caused by K+ loss. They responded well to K+ supplementation. Conclusion, Due to the inhibition of the ACE2 enzyme, which controls blood pressure by controlling potassium's activity in several metabolic processes, the coronavirus lowers potassium levels, which in turn impacts respiratory symptoms and pulmonary function. The majority of COVID-19 patients have hypokalemia. Due to ongoing renal K+ loss brought on by the breakdown of ACE2, treating hypokalemia is difficult. A favorable prognosis is indicated by the cessation of K+ loss, and it may be dependable., As a result, it is important to keep track of potassium levels when the body is infected with the virus, which is what the research's findings targeted.
Downloads
References
Amal Talib Al Sa’ady, Z.A.A., Ali Fadhil Obaid,
HayderAbdul-Amir Makki Alhindy, Amir S. AlMumin Prevalence of adverse effects from
COVID-19 vaccine among Iraqi adults: A
retrospective cross-sectional study. Journal of
Emergency Medicine, Trauma Acute Care,
3(6): p. 1-9.
Rothan, H.A. and S.N. Byrareddy, The epidemiology
and pathogenesis of coronavirus disease (COVID-19)
outbreak. J Autoimmun, 2020. 109: p. 102433.
Jain, U., Effect of COVID-19 on the Organs.
Cureus, 2020. 12(8): p. e9540.
Hayder Abdul-Amir Maki Al-Hindy, J.M., HO
Hashim, BCG Vaccine in preventing COVID-19
epidemic had to be reviewed: correlation does not
imply causation. Australian Journal of Basic and
Applied Sciences, 2021. 14(11): p. 58-63.
Cui, J., F. Li, and Z.L. Shi, Origin and evolution
of pathogenic coronaviruses. Nat Rev Microbiol,
17(3): p. 181-192.
Noori, M., et al., How SARS-CoV-2 might affect
potassium balance via impairing epithelial sodium
channels? Mol Biol Rep, 2021. 48(9): p. 6655-
Alfano, G., et al., Hypokalemia in Patients with
COVID-19. Clin Exp Nephrol, 2021. 25(4): p.
-409.
Obukhov, A.G., et al., SARS-CoV-2
Infections and ACE2: Clinical Outcomes
Linked With Increased Morbidity and
Mortality in Individuals With Diabetes.
Diabetes, 2020. 69(9): p. 1875-1886.
Noori, M., et al., A Review on the Possible
Pathophysiology of Potassium Abnormalities in
COVID-19. Iran J Kidney Dis, 2021. 15(6): p.
-407.
Ribeiro SC, F.A., Barretti P, Pecoits-Filho R, de
Moraes TP, Low Serum Potassium Levels Increase
the Infectious-Caused Mortality in Peritoneal
Dialysis Patients: A Propensity-Matched Score
Study. PLoS ONE 2015. 10(6): p. e0127453.
Tanaka, T., et al., A simple method to estimate
populational 24-h urinary sodium and potassium
excretion using a casual urine specimen. Journal
of Human Hypertension, 2002. 16(2): p. 97-103.
Brown, I.J., et al., Estimating 24-hour urinary
sodium excretion from casual urinary sodium
concentrations in Western populations: the
INTERSALT study. Am J Epidemiol, 2013.
(1l):p. 1180-92.
Kawasaki, T., et al., A simple method for
estimating 24 h urinary sodium and potassium
excretion from second-morning voiding urinepecimen in adults. Clin Exp Pharmacol Physiol,
20(1): p. 7-14.
Chen, Y., et al., Disordered signaling governing
ferroportin transcription favors breast cancer
growth. Cell Signal, 2015. 27(1): p. 168-76.
Tentori, F, et al., SP498INTERNATIONAL
VARIABILITY IN THE PREVALENCE OF
HYPOKALEMIA AMONG PATIENTS ON
PERITONEAL DIALYSIS (PD): RESULTS FROM
THE PDOPPS. Nephrology Dialysis Transplantation,
32(suppl_3): p. iii296-iii296.
Tennankore, K., et al., The Association of
Functional Status with Mortality and Dialysis
Modality Change: Results from the Peritoneal
Dialysis Outcomes and Practice Patterns Study
(PDOPPS). Perit Dial Int, 2019. 39(2): p. 103-
Karim Abdul-Husseein, H., et al., Liver
Function Abnormalities in COVID-19 Patients
and their Association with Age and Sex: a CrossSectional Study. Archives of Razi Institute, 2023.
(1): p. 453-458.
Carney, S.L., N.L. Wong, and J.H. Dirks, Effect
of magnesium deficiency and excess on renal
tubular potassium transport in the rat. Clin Sci
(Lond), 1981. 60(5): p. 549-54.
Palmer, B.F. and D.J. Clegg, Physiology and
Pathophysiology of Potassium Homeostasis: Core
Curriculum 2019. American Journal of Kidney
Diseases, 2019. 74(5): p. 682-695
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
